Editor's Comparative Analysis
When choosing between 生物医学转化 and ARS Medica, researchers should consider the trade-off between prestige (ARS Medica leads with an IF of ) and cost-efficiency, as 生物医学转化 is a Diamond Open Access venue.
生物医学转化 is published in CN, while ARS Medica is headquartered in CL. Both titles are verified via the JournalsHub Live Indexing Tracker for 2026.
| Academic Metric | 生物医学转化 | ARS Medica |
|---|---|---|
| General Information | ||
| Publisher | Lanzhou University Press | Pontificia Universidad Católica de Chile |
| Country of Origin | CN | CL |
| Established | 2024 | 2023 |
| Editor-in-Chief | See Website | See Website |
| Scientific Influence | ||
| Current Impact Factor | N/A | N/A |
| Indexing Status |
DOAJ
|
DOAJ
|
| Review Speed (Decision) | Unknown |
70 days
Standard
|
| Acceptance Rate | N/A | N/A |
| Access & Publication Fees | ||
| Open Access Type | Full OA | Full OA |
| APC Fee (Estimated) | FREE (Diamond) | FREE (Diamond) |
Historical Impact Factor Comparison
No historical impact factor data available for these journals yet.
About 生物医学转化
生物医学转化 is a prominent academic journal specializing in Biotechnology and Medicine. Published by Lanzhou University Press in CN, the journal serves as an essential platform for researchers to share high-quality scholarly work. It is fully Open Access publication identified by ISSN 2096-8965. The journal aims to advance the boundaries of …
View Full ProfileAbout ARS Medica
ARS Medica is a prominent academic journal specializing in Medicine. Published by Pontificia Universidad Católica de Chile in CL, the journal serves as an essential platform for researchers to share high-quality scholarly work. It is fully Open Access publication identified by ISSN 0718-1051. The journal aims to advance the boundaries …
View Full ProfileSearching for: 生物医学转化 impact factor, ARS Medica APC fees, journal comparison tool 2026.